Results 121 to 130 of about 128,118 (293)

Abstract #1393925: An Interesting Case of Bisphosphonate Resistant Hypercalcemia in Acute Myelogenous Leukemia (AML) [PDF]

, 2023
Sara Cohen, Fatima Kazi, Norma López
openalex   +1 more source

Chronic myelogenous leukemia evolving after treatment of multiple myeloma [PDF]

, 2016
Denise Wolleschak, Florian H. Heidel
openalex   +1 more source

Typical Chronic Myelogenous Leukemia With e19a2 Junction BCR/ABL Transcript [PDF]

, 1997
Montserrat Briz, Carlos Vilches, Rafael Cabrera, Rafael Forés, Manuel N. Fernández   +4 more
openalex   +1 more source

Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission [PDF]

, 1987
Zeev Estrov, ID Dube, HS Chan, MH Freedman   +3 more
openalex   +1 more source

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Blood, 1975
C. Lozzio, B. Lozzio
semanticscholar   +1 more source

Acute myelogenous leukaemia in children

European Journal of Pediatrics, 1989
Acute myelogenous leukaemia in childhood is considerably more resistant to chemotherapy than the acute lymphocytic leukaemias. Recently, more aggressive therapy has improved the outlook for children with this difficult form of leukaemia. Long-term disease-free survival of children achieving remission has been reported to be more than 40% in some ...
openaire   +3 more sources

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.

Cancer Discovery, 2016
M. Konopleva, D. Pollyea, J. Potluri, B. Chyla, L. Hogdal, T. Busman, E. Mckeegan, A. Salem, Ming Zhu, J. Ricker, W. Blum, C. Dinardo, T. Kadia, M. Dunbar, R. Kirby, N. Falotico, J. Leverson, R. Humerickhouse, M. Mabry, R. Stone, H. Kantarjian, A. Letai   +21 more
semanticscholar   +1 more source

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.

New England Journal of Medicine, 2002
H. Kantarjian, C. Sawyers, A. Hochhaus, F. Guilhot, C. Schiffer, C. Gambacorti-Passerini, D. Niederwieser, D. Resta, R. Capdeville, U. Zoellner, M. Talpaz, B. Druker, J. Goldman, S. O’Brien, N. Russell, T. Fischer, O. Ottmann, P. Cony-Makhoul, T. Facon, R. Stone, Carole B. Miller, M. Tallman, R. Brown, M. Schuster, T. Loughran, A. Gratwohl, F. Mandelli, G. Saglio, M. Lazzarino, D. Russo, M. Baccarani, E. Morra   +31 more
semanticscholar   +1 more source

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

New England Journal of Medicine, 2005
B. Falini, C. Mecucci, E. Tiacci, M. Alcalay, R. Rosati, L. Pasqualucci, R. la Starza, D. Diverio, E. Colombo, A. Santucci, B. Bigerna, R. Pacini, A. Pucciarini, A. Liso, M. Vignetti, P. Fazi, Natalia Meani, V. Pettirossi, G. Saglio, F. Mandelli, F. Lo‐Coco, P. Pelicci, M. Martelli   +22 more
semanticscholar   +1 more source

SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway

, 2015
Hua Xu, Yuanye Li, Long Chen, Chijuan Wang, Qi Wang, Hairui Zhang, Yani Lin, Qinghua Li, Tianxiang Pang   +8 more
openalex   +2 more sources